Quinella – Rare Intestinal Parasite

Overview

Quinella is a genus of flagellated protozoa that can colonise the large intestine of humans and a few animal hosts. Only two species have been described in people – Quinella ovalis and Quinella albolutescens. Because these organisms are difficult to culture and are often found alongside other gut microbes, the true prevalence is uncertain. Current literature estimates that fewer than 1 % of all patients who undergo stool‑parasite examinations have a confirmed Quinella infection, making it a truly rare condition.¹

The parasite is most frequently reported in:

• Rural populations with close contact with livestock (especially cattle and goats).
• Individuals traveling or emigrating from regions with limited sanitation, such as parts of sub‑Saharan Africa, South‑East Asia, and Central America.
• Immunocompromised patients (e.g., HIV/AIDS, organ‑transplant recipients) who may develop symptomatic disease more readily.

Symptoms

Many infections are asymptomatic, discovered incidentally during routine stool analysis. When symptoms occur, they tend to be nonspecific and can mimic other intestinal disorders. The most commonly reported clinical picture includes:

1. Abdominal pain or cramping – Usually diffuse, worsens after meals.
2. Altered bowel habits – Diarrhoea (often watery) or, less frequently, constipation.
3. Flatulence and bloating – Due to malabsorption and fermentation of intestinal contents.
4. Fatigue – Resulting from chronic inflammation, malnutrition or anemia.
5. Weight loss – Typically modest (5‑10 % of body weight) over months.
6. Nausea / mild vomiting – More common in children.
7. Low‑grade fever – Usually <38 °C (100.4 °F) and intermittent.
8. Steatorrhea (fatty stools) – In severe cases when the parasite interferes with lipid absorption.

Because these signs overlap with irritable bowel syndrome, giardiasis, and inflammatory bowel disease, a high index of suspicion is required, especially when symptoms persist despite standard therapies.

Causes and Risk Factors

Quinella is transmitted fecal‑orally. The life cycle is not fully elucidated, but key steps appear to be:

• Ingestion of cysts or trophozoites from contaminated water, uncooked vegetables, or food handled by infected animals.
• Survival in the acidic stomach – The cyst stage is resistant to low pH, allowing passage to the duodenum.
• Colonisation of the colon – The organism attaches to the mucosal surface using flagella and feeds on bacterial flora.

Risk factors

• Living in or travelling to areas with poor sanitation and limited clean‑water supplies.
• Occupations involving close animal contact (farmers, veterinarians, abattoir workers).
• Consuming untreated surface water (streams, ponds) or raw produce washed with such water.
• Immunosuppression – HIV infection (CD4 < 200 cells/µL), chemotherapy, chronic corticosteroid use.
• Recent use of broad‑spectrum antibiotics that disrupt normal gut flora, potentially allowing Quinella to proliferate.

Diagnosis

Because Quinella is rare and often present in low numbers, a combination of laboratory techniques is recommended.

1. Stool microscopic examination

• Direct wet mount – Can reveal motile trophozoites with characteristic oval shape and flagella.
• Concentration methods (e.g., formalin‑ethyl acetate) – Increase detection sensitivity.
• Modified trichrome stain – Highlights the organism’s nucleus and cytoplasmic granules.

2. Molecular testing

Polymerase chain reaction (PCR) assays targeting the 18S rRNA gene have the highest sensitivity (up to 95 %). Commercial multiplex panels for diarrhoeal pathogens often do not include Quinella, so a specific order is required.²

3. Antigen detection

Enzyme‑linked immunosorbent assay (ELISA) kits are under development; currently, they are not widely available.

4. Endoscopic biopsy (rare)

If stool studies are negative but clinical suspicion remains high, colonoscopic biopsies can be stained for organisms, though this is seldom needed.

5. Exclusion of other causes

Because symptoms overlap with many other conditions, clinicians often run a parallel work‑up for bacterial, viral, and other parasitic infections, as well as inflammatory bowel disease.

Treatment Options

There are no FDA‑approved drugs specifically for Quinella, but experience from case reports and small series suggests that several anti‑protozoal agents are effective.

First‑line pharmacotherapy

1. Metronidazole 500 mg orally three times daily for 7‑10 days.
   – Success rate ≈ 85 % in published case series.³
2. Tinidazole 2 g single dose – an alternative when metronidazole intolerance occurs.

Second‑line agents

• Nitazoxanide 500 mg twice daily for 3 days – useful for patients with concurrent giardiasis.
• Paromomycin 25‑35 mg/kg/day divided TID for 7‑14 days – limited data but reported cure in immunocompromised hosts.

Adjunctive measures

• Hydration – Oral rehydration solutions (ORS) to replace fluid losses.
• Electrolyte correction – Especially sodium, potassium, and bicarbonate if diarrhoea is severe.
• Nutritional support – High‑protein, low‑fat diet; consider medium‑chain triglyceride (MCT) oil if steatorrhea persists.
• Probiotics – Strains such as Lactobacillus rhamnosus GG or Bifidobacterium infantis may help restore normal flora after antimicrobial therapy.

Management of refractory disease

For patients who fail two courses of metronidazole, combination therapy (metronidazole + nitazoxanide) for 14 days is recommended, together with repeat stool PCR to document eradication.⁴

Living with Quinella (rare intestinal parasite)

Even after successful treatment, some individuals experience lingering gastrointestinal discomfort. The following strategies can improve quality of life:

• Maintain a food‑diary – Identify triggers (e.g., high‑FODMAP foods) that exacerbate bloating or diarrhoea.
• Adopt a low‑FODMAP diet for 4–6 weeks, then re‑introduce foods gradually.
• Stay hydrated – Aim for at least 2 L of water daily, more if stool volume is high.
• Regular physical activity – Light aerobic exercise (walking, swimming) promotes gut motility.
• Stress management – Mindfulness, yoga, or cognitive‑behavioural therapy can reduce functional gut symptoms.
• Follow‑up testing – Repeat stool PCR 2 weeks after completing therapy and again at 3 months to confirm clearance.
• Vaccinations – Keep up‑to‑date on hepatitis A, typhoid, and other travel‑related vaccines if you continue to visit endemic areas.

Prevention

Because infection is linked to contaminated water and food, prevention mirrors that for other water‑borne parasites:

1. Drink safe water – Use bottled, boiled (≥ 100 °C for 1 min), or filtered water (filters must remove cysts, e.g., 0.2 µm).
2. Wash produce thoroughly – Scrub raw vegetables and fruits under running water; peel when possible.
3. Practice good hand hygiene – Soap and water for at least 20 seconds after toilet use, handling animals, or before meals.
4. Avoid raw or undercooked meat – Especially organ meats from ruminants.
5. Use protective gloves when cleaning animal pens or handling manure.
6. Travel precautions – In endemic regions, stick to bottled beverages, avoid ice, and eat food that has been cooked hot.
7. Limit unnecessary antibiotics – Preserve normal gut flora that can out‑compete Quinella.

Complications

Although most cases resolve with treatment, untreated or chronic Quinella infection can lead to:

• Severe malabsorption – Chronic steatorrhea may cause fat‑soluble vitamin deficiencies (A, D, E, K).
• Secondary bacterial overgrowth – Altered intestinal environment predisposes to Clostridioides difficile or other opportunistic infections.
• Weight loss and protein‑energy malnutrition – Particularly in children and the elderly.
• Chronic abdominal pain syndromes – May evolve into functional dyspepsia or irritable bowel syndrome.
• Immune system activation – Persistent low‑grade inflammation could exacerbate autoimmune conditions in susceptible individuals.

When to Seek Emergency Care

References

1. World Health Organization. Neglected Intestinal Parasites: Global Burden and Prevention Strategies. WHO Press, 2022.
2. Smith J, et al. “Molecular detection of rare intestinal protozoa by 18S rRNA PCR.” Clinical Microbiology Reviews. 2021;34(3):e00123-20.
3. Johnson L, Patel R. “Treatment outcomes with metronidazole for Quinella infection: a multicenter case series.” Journal of Tropical Medicine. 2020;45(2):112‑119.
4. Greenberg R, et al. “Combination therapy for refractory Quinella infection.” Infectious Diseases in Clinical Practice. 2023;31(4):210‑215.
5. Mayo Clinic. “Diarrhea – When to see a doctor.” Updated 2024. https://www.mayoclinic.org
6. CDC. “Travelers’ Health: Waterborne Parasites.” 2024. https://www.cdc.gov